Exicure, Inc. today shared updates on its lead asset, GPC-100 (burixafor), a small molecule CXCR4 inhibitor. Exicure, Inc. ("Exicure") is planning for a clinical trial in Acute Myeloid Leukemia (AML) ...

The 71st Greater San Diego Science and Engineering Fair (GSDSEF) was held this year at the Balboa Park Activity Center, on Wednesday, March 12th. The awards ceremony was held on Thursday, March 13th ...